Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sensus Healthcare, Inc. (SRTS)
Price$3.12Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27.5M | $41.8M | $24.4M | $44.5M | $27.0M | $9.6M | $27.3M | $26.4M | $20.6M | $14.8M | $10.3M |
| Gross profit | $11.9M | $24.4M | $14.1M | $29.6M | $17.0M | $5.2M | $17.6M | $16.9M | $13.8M | $9.8M | $6.6M |
| Gross margin | 43.18% | 58.44% | 57.61% | 66.53% | 62.82% | 54.81% | 64.40% | 63.99% | 67.03% | 66.48% | 64.05% |
| Research & development | $7.8M | $4.2M | $3.7M | $3.5M | $3.4M | $4.2M | $6.4M | $6.3M | $5.5M | $1.8M | $1.5M |
| Operating expenses | $22.2M | $16.3M | $14.4M | $14.8M | $12.9M | $13.5M | $19.5M | $18.9M | $17.5M | $10.2M | $6.8M |
| Operating income | −$10.3M | $8.1M | −$382,000 | $14.8M | $4.1M | −$8.2M | −$2.0M | −$2.0M | −$3.7M | −$363,119 | −$221,257 |
| Operating margin | −37.50% | 19.35% | −1.57% | 33.30% | 15.24% | −85.98% | −7.22% | −7.59% | −18.06% | −2.45% | −2.15% |
| EBITDA | −$9.9M | $8.3M | −$107,000 | $15.1M | $4.7M | −$7.5M | −$1.4M | −$1.3M | −$3.3M | −$25,536 | $94,342 |
| EBITDA margin | −36.05% | 19.83% | −0.44% | 34.01% | 17.50% | −78.44% | −5.22% | −5.10% | −16.17% | −0.17% | 0.92% |
| Net income | −$7.7M | $6.6M | $485,000 | $24.2M | $4.1M | −$6.8M | −$1.7M | −$2.0M | −$3.7M | −$346,448 | −$237,267 |
| Net profit margin | −28.09% | 15.90% | 1.99% | 54.44% | 15.23% | −71.38% | −6.24% | −7.65% | −18.02% | −2.34% | −2.31% |
| Basic EPSper basic share | -$0.47 | $0.41 | $0.03 | $1.47 | $0.25 | -$0.42 | -$0.10 | -$0.14 | -$0.28 | -$0.03 | -$0.08 |
| Diluted EPSper diluted share | -$0.47 | $0.41 | $0.03 | $1.46 | $0.25 | -$0.42 | -$0.10 | -$0.14 | -$0.28 | -$0.03 | -$0.08 |
Owners
Reported shareholders
≈7.29%of listed shares
Sardano Joseph C1.2M shares · Nov 18, 2025
View holders
| Holder | % owned |
|---|---|
Sardano Joseph C | ≈7.29%1.2M shares |
Pacific Ridge Capital Partners, LLC | 4.80%789.68K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.01%660.4K shares |
DIMENSIONAL FUND ADVISORS LP | 1.92%316.12K shares |
Divisadero Street Capital Management, LP | 1.69%278.49K shares |
RENAISSANCE TECHNOLOGIES LLC | 1.47%242.33K shares |
Sardano Michael | ≈0.97%159.84K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.94%154.15K shares |
UBS Group AG | 0.93%152.57K shares |
Sachetta, LLC | 0.92%152.01K shares |
Sachetta Eric | ≈0.89%145.71K shares |
Greenline Wealth Management LLC | 0.78%128.77K shares |
North Star Investment Management Corp. | 0.76%125.59K shares |
Bank of New York Mellon Corp | 0.61%100.41K shares |
BlackRock, Inc. | 0.51%83.56K shares |
VANGUARD FIDUCIARY TRUST CO | 0.46%76.29K shares |
STATE STREET CORP | 0.42%69.25K shares |
Petrelli Anthony Benedict | ≈0.40%66.47K shares |
INGALLS & SNYDER LLC | 0.33%55K shares |
MINDSET WEALTH MANAGEMENT, LLC | 0.32%52.1K shares |
Percentages use 16.46M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 12, 2026Form 4 | Sachetta EricDirector | BuyCommon Stock | 1.5K | $3.34 | $5.0K | 143.6K |
| Feb 24, 2026Form 4 | Sachetta EricDirector | BuyCommon Stock | 2.0K | $3.81 | $7.6K | 142.1K |
| Nov 21, 2025Form 4 | Sachetta EricDirector | BuyCommon Stock | 7.0K | $3.93 | $27.5K | 140.1K |
| Nov 18, 2025Form 4 | Sardano MichaelPRESIDENT AND GENERAL COUNSEL | BuyCommon Stock | 1.0K | $3.80 | $3.8K | 118.8K |
| Nov 18, 2025Form 4 | Sardano Joseph CCHIEF EXECUTIVE OFFICER | BuyCommon Stock | 25.0K | $4.03 | $100.8K | 1.20M |